Radolfzell
Germany
66
2025-03-13
The entities that hold a legal rights for patent applications filed by inventor Klein Thomas:
Thomas Klein from Radolfzell, DE has applied for patents for these inventions. The list has both pending applications and granted patents:
TREATMENT FOR DIABETES IN PATIENTS WITH INSUFFICIENT GLYCEMIC CONTROL DESPITE THERAPY WITH AN ORAL OR NON-ORAL ANTIDIABETIC DRUG
#2 | 2025-01-23CARDIO- AND RENOPROTECTIVE ANTIDIABETIC THERAPY
#3 | 2024-10-10PHARMACEUTICAL COMPOSITION, METHODS FOR TREATING AND USES THEREOF
#4 | 2024-09-12USE OF A DPP-4 INHIBITOR IN PODOCYTES RELATED DISORDERS AND/OR NEPHROTIC SYNDROME
#5 | 2024-05-16VASOPROTECTIVE AND CARDIOPROTECTIVE ANTIDIABETIC THERAPY
#6 | 2024-05-09TREATMENT FOR DIABETES IN PATIENTS WITH INSUFFICIENT GLYCEMIC CONTROL DESPITE THERAPY WITH AN ORAL ANTIDIABETIC DRUG
#7 | 2024-02-01CARDIO- AND RENOPROTECTIVE ANTIDIABETIC THERAPY
#8 | 2023-12-21PHARMACEUTICAL COMPOSITION, METHODS FOR TREATING AND USES THEREOF
#9 | 2022-10-27Use of a DPP-4 inhibitor in SIRS and/or sepsis
#10 | 2022-05-19PHARMACEUTICAL COMPOSITION, METHODS FOR TREATING AND USES THEREOF
#11 | 2022-03-31PHARMACEUTICAL COMPOSITION, METHODS FOR TREATING AND USES THEREOF
#12 | 2021-12-09USE OF A DPP-4 INHIBITOR IN PODOCYTES RELATED DISORDERS AND/OR NEPHROTIC SYNDROME
#13 | 2021-07-15COMBINATIONS COMPRISING AN SSAO/VAP-1 INHIBITOR AND A SGLT2 INHIBITOR, USES THEREOF
#14 | 2021-07-08CARDIO- AND RENOPROTECTIVE ANTIDIABETIC THERAPY
#15 | 2021-06-03Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral or non-oral antidiabetic drug
#16 | 2021-04-29Vasoprotective and cardioprotective antidiabetic therapy
#17 | 2021-04-22PHARMACEUTICAL COMPOSITION, METHODS FOR TREATING AND USES THEREOF
#18 | 2020-12-24PHARMACEUTICAL COMPOSITION, METHODS FOR TREATING AND USES THEREOF
#19 | 2020-10-29CARDIO- AND RENOPROTECTIVE ANTIDIABETIC THERAPY
#20 | 2020-08-27PHARMACEUTICAL COMPOSITION, METHODS FOR TREATING AND USES THEREOF
#21 | 2020-05-21TREATMENT FOR DIABETES IN PATIENTS WITH INSUFFICIENT GLYCEMIC CONTROL DESPITE THERAPY WITH AN ORAL ANTIDIABETIC DRUG
#22 | 2019-07-04USE OF A DPP-4 INHIBITOR IN SIRS AND/OR SEPSIS
#23 | 2019-06-27CARDIO- AND RENOPROTECTIVE ANTIDIABETIC THERAPY
#24 | 2019-04-04USE OF A DPP-4 INHIBITOR IN PODOCYTES RELATED DISORDERS AND/OR NEPHROTIC SYNDROME
#25 | 2018-09-20CARDIO- AND RENOPROTECTIVE ANTIDIABETIC THERAPY
#26 | 2018-08-02PHARMACEUTICAL COMPOSITION, METHODS FOR TREATING AND USES THEREOF
#27 | 2018-07-12PHARMACEUTICAL COMPOSITION, METHODS FOR TREATING AND USES THEREOF
#28 | 2018-04-19Pharmaceutical Composition, Methods for Treating and Uses Thereof
#29 | 2017-12-28TREATMENT FOR DIABETES IN PATIENTS WITH INSUFFICIENT GLYCEMIC CONTROL DESPITE THERAPY WITH AN ORAL OR NON-ORAL ANTIDIABETIC DRUG
#30 | 2017-11-30VASOPROTECTIVE AND CARDIOPROTECTIVE ANTIDIABETIC THERAPY
#31 | 2017-10-26PHARMACEUTICAL COMPOSITION, METHODS FOR TREATING AND USES THEREOF
#32 | 2017-06-01Combination therapy
#33 | 2017-03-09CARDIO- AND RENOPROTECTIVE ANTIDIABETIC THERAPY
#34 | 2017-03-09Use of a DPP-4 inhibitor in podocytes related disorders and/or nephrotic syndrome
#35 | 2016-07-21PURIN DERIVATIVES FOR USE IN THE TREATMENT OF FAB-RELATED DISEASES
#36 | 2016-03-31CARDIO- AND RENOPROTECTIVE ANTIDIABETIC THERAPY
#37 | 2016-03-24Use of a DPP-4 inhibitor in podocytes related disorders and/or nephrotic syndrome
#38 | 2016-03-03TREATMENT FOR DIABETES IN PATIENTS WITH INSUFFICIENT GLYCEMIC CONTROL DESPITE THERAPY WITH AN ORAL OR NON-ORAL ANTIDIABETIC DRUG
#39 | 2016-02-11Combination therapy
#40 | 2015-09-03Medical use of a DPP-4 inhibitor
#41 | 2015-07-16VASOPROTECTIVE AND CARDIOPROTECTIVE ANTIDIABETIC THERAPY
#42 | 2015-04-23Substituted quinazolines, the preparation thereof and the use thereof in pharmaceutical compositions
#43 | 2014-12-18MEDICAL USE OF A DPP-4 INHIBITOR
#44 | 2014-11-20COMBINATION OF A CERTAIN DPP-4 INHIBITOR AND VOGLIBOSE
#45 | 2014-09-18CARDIO- AND RENOPROTECTIVE ANTIDIABETIC THERAPY
#46 | 2014-09-11PHARMACEUTICAL COMPOSITION, METHODS FOR TREATING AND USES THEREOF
#47 | 2014-08-14Substituted quinazolines, the preparation thereof and the use thereof in pharmaceutical compositions
#48 | 2014-03-27PHARMACEUTICAL COMPOSITION COMPRISING AN SGLT2 INHIBITOR AND A PPAR- GAMMA AGONIST AND USES THEREOF
#49 | 2014-03-27PHARMACEUTICAL COMPOSITION, METHODS FOR TREATING AND USES THEREOF
#50 | 2013-12-05Method for modifying food intake and regulating food preference with a DPP-4 inhibitor
#51 | 2013-11-28USE OF KERATINOCYTES AS A BIOLOGICALLY ACTIVE SUBSTANCE IN THE TREATMENT OF WOUNDS, SUCH AS DIABETIC WOUNDS, OPTIONALLY IN COMBINATION WITH A DPP-4 INHIBITOR
#52 | 2013-11-14USE OF A DPP-4 INHIBITOR IN SIRS AND/OR SEPSIS
#53 | 2013-11-14USE OF A DPP-4 INHIBITOR IN PODOCYTES RELATED DISORDERS AND/OR NEPHROTIC SYNDROME
#54 | 2013-10-24Combination therapy
#55 | 2013-09-26Pharmaceutical composition, methods for treating and uses thereof
#56 | 2013-07-18Substituted quinazolines, the preparation thereof and the use thereof in pharmaceutical compositions
#57 | 2013-07-04SUBCUTANEOUS THERAPEUTIC USE OF DPP-4 INHIBITOR
#58 | 2013-02-07PHARMACEUTICAL COMPOSITION, METHODS FOR TREATING AND USES THEREOF
#59 | 2012-11-08PHARMACEUTICAL COMPOSITION, METHODS FOR TREATING AND USES THEREOF
#60 | 2012-06-28Diabetes therapy
#61 | 2012-05-24COMBINATION TREATMENT FOR DIABETES MELLITUS
#62 | 2012-05-17Vasoprotective and cardioprotective antidiabetic therapy
#63 | 2011-11-10Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral or non-oral antidiabetic drug
#64 | 2011-08-04PURIN DERIVATIVES FOR USE IN THE TREATMENT OF FAB-RELATED DISEASES
#65 | 2011-04-21DPP-IV INHIBITORS FOR USE IN THE TREATMENT OF NAFLD
#66 | 2010-07-15Combination treatment for diabetes mellitus
79782 ⎘